Because we haven't heard anything public from Danaher or Cepheid, I've tried reaching execs there. It hasn't gone great, but they have my phone number and email. They know how to get in touch with MSF. We want to work with them and make this a win for them. The GeneXpert Machine is so awesome--but tests aren't getting to nearly enough people who need them. Improving access isn't easy. I know that. It IS possible--but not if @DanaherCorp and Cepheid think the only response to public pressure is radio silence.

I want to be clear that while I think our pressure may have affected the timing, this must have been in the works for a while. The real heroes here aren't us but the Stop TB Partnership and other activists who've been working for YEARS to get to this moment. You rule. THANK YOU.

!!!!!!!!!!!!! @JNJNews, THANK YOU for choosing #PatientsNotPatents. Takes real guts to live up to your credo. Generic bedaquiline WILL BE AVAILABLE in almost every country with a high tuberculosis burden. I am so happy and grateful to the Stop TB Partnership, J&J, and especially the activists around the world who are standing up for TB patients. So much more work to do, but WHAT WONDERFUL NEWS TO WAKE UP TO.

Tell @JNJNews their attempts to evergreen the patent on the life-saving tuberculosis drug bedaquiline is unjust and a violation of their corporate credo: secure.ethicspoint.com/domai… And then tell the world that Johnson & Johnson is denying MILLIONS access to life-saving TB treatment.

One of the reasons tuberculosis continues to infect and kill more people is because you refuse to allow the widespread distribution of affordable bedaquiline, which is essential to stopping the spread of multidrug-resistant tuberculosis and curing those infected by it. It takes some gall to wonder aloud what the problem is when you know that you are the problem. You've had 20 years of a bedaquiline monopoly. You've made your money. ENOUGH.